Featured
National Health Leaders Call for Coordinated Action to Accelerate Cervical Cancer Elimination in India-TBT
National Health Leaders Call for Coordinated Action to Accelerate Cervical Cancer Elimination in India
Rabbits
When Rabbits Stop Eating: Looking Beyond the Teeth – The Emerging Role of Cone Beam CT in Rabbit Dental Disease
Bench Mark Infotech
Bench Mark Infotech Services Limited to Launch IPO on NSE Emerge; Offer Opens September 25, 2026
September 22, 2026
The Blunt Times The Blunt Times
  • National
  • City Events
  • Business Vibes
  • Education
  • Entertainment
  • Regional
    • Bharuch
    • Dang
    • Navsari
    • Surat
    • Valsad
    • Hindi
    • Gujarati
  • Health
  • Crime corner
  • Sports
  • Spotlight
Search the Site
Popular Searches:
Chatgpt Nasa Halloween
Recent Posts
MYCPE ONE Operational Excellence Award, the blunt times
MYCPE ONE bags operational excellence & quality award at Asia Pacific HRM Congress Awards
September 21, 2026
PanIIT
PanIIT Alumni India Completes 20 Years, Sets Roadmap for Its Third Decade
September 21, 2026
Syedna Mufaddal Saifuddin honorary doctorate, the blunt times
University of Kufa honours Dawoodi Bohra leader Syedna Mufaddal Saifuddin
September 21, 2026
The Blunt Times The Blunt Times
  • National
  • City Events
  • Business Vibes
  • Education
  • Entertainment
  • Regional
    • Bharuch
    • Dang
    • Navsari
    • Surat
    • Valsad
    • Hindi
    • Gujarati
  • Health
  • Crime corner
  • Sports
  • Spotlight
Follow us
Home/Business Vibes/JLF Life Sciences IPO intends to raise Rs 1816 lakh through 29.78 lakh equity shares
Business Vibes

JLF Life Sciences IPO intends to raise Rs 1816 lakh through 29.78 lakh equity shares

[ad_1] New Delhi [India] : JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having experience of more than a decade, is all set to raise Rs 1,816.58 Lakhs...

Times News Service
August 26, 2022 2 Min Read

[ad_1]

New Delhi [India] : JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having experience of more than a decade, is all set to raise Rs 1,816.58 Lakhs through an initial public offering (IPO). The issue opened on the 25th of August and listed on NSE Emerge.

The public issue of JFL Life Sciences Limited is of 29,78,000 equity shares of Face Value ₹10 each (“EQUITY SHARES”) for cash at a price of ₹ 61/- per equity share (including a securities premium of ₹ 51/- per equity share) (the issue price) aggregating ₹ 1,816.58 LACS of the issue. 1,50,000 equity shares aggregating to ₹ 91.50 Lakhs will be reserved for market maker (“Market Maker Reservation Portion”). The issue, less the Market Maker Reservation Portion, i.e., issue of 28,28,000 equity shares of Face Value of ₹ 10/- EACH at an issue price of ₹ 61/- per equity share, aggregating to ₹ 1,725.08 Lakhs, which is hereinafter referred to as “The Net Issue”. The issue and the Net Issue will constitute 27.08% AND 25.71%, respectively of the post issue paid up equity share capital of the company. The company will list at NSE Emerge. The Lead manager of the issue is GYR Capital Advisors Pvt Ltd and the Registrar to the issue is KFin Technologies Ltd. The issue opens on the 25th of August and will close on the 30th of August, 2022 and will subsequently be listed on NSE Emerge.

The company intends to utilize the proceeds of the Issue to meet the following objectives:

1. Repayment of secured and unsecured loans

2. Funding the working capital requirements of the company

3. General Corporate Purposes

 

 

JFL Life Sciences Limited is engaged in the business of manufacturing pharmaceutical products. Their product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS). With market presence in pan India, products of JFL supplies to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.

 

The Company has registered their products to manufacture in various countries like sovereign of Kenya, Nigeria, Yemen & Myanmar. Few of their products are also registered with Ukraine, Uzbekistan, and Kazakhstan as well. This also makes them a ‘one-stop-shop’ service provider for catering to all of the customer’s needs domestically as well as internationally.

The promoters, Mr. Smiral Ashwinbhai Patel and Tejal Smiralbhai Patel are actively involved in the day-to-day business of the company and are the guiding force behind the strategic decisions for the Company. Their management team and other key management personnel are well qualified and have extensive industry expertise, and have been responsible for the operational growth.



[ad_2]

Share Article

Previous Post

Lorein Finance clocks USD 75 million in student loan applications within weeks of its launch

Next Post

EZOK brand for men’s footwear launched with 150 SKUs

Picked
Khavda
Khavda Transmission Corridor. Powering India’s Green Transition
National Health Leaders Call for Coordinated Action to Accelerate Cervical Cancer Elimination in India-TBT
National Health Leaders Call for Coordinated Action to Accelerate Cervical Cancer Elimination in India
Rabbits
When Rabbits Stop Eating: Looking Beyond the Teeth – The Emerging Role of Cone Beam CT in Rabbit Dental Disease
Bench Mark Infotech
Bench Mark Infotech Services Limited to Launch IPO on NSE Emerge; Offer Opens September 25, 2026
Forteasia Realty
Forteasia Realty Accelerates Haryana’s Industrial Transformation with 135+ Acre Forteasia Industrial Township
AlgoShack to Showcase AI-Augmented Autonomous Quality Engineering at Mangaluru Technovanza 2026-TBT
AlgoShack to Showcase AI-Augmented Autonomous Quality Engineering at Mangaluru Technovanza 2026
Popular Posts
Forteasia Realty
Forteasia Realty Accelerates Haryana’s Industrial Transformation with 135+ Acre Forteasia Industrial Township
By TBT Online Desk
AlgoShack to Showcase AI-Augmented Autonomous Quality Engineering at Mangaluru Technovanza 2026-TBT
AlgoShack to Showcase AI-Augmented Autonomous Quality Engineering at Mangaluru Technovanza 2026
By TBT Online Desk
GD Goenka
Mission Kamyab Launches Scholarship Exam for JEE and NEET at GD Goenka
By TBT Online Desk
Sri Sri Wellbeing Reopens Expanded Satellite Centre with Doctor-Led Ayurveda Care
Sri Sri Wellbeing Reopens Expanded Satellite Centre with Doctor-Led Ayurveda Care
By TBT Online Desk
HubbleHox
HubbleHox and II-TED Partner with FutureSkills Prime to Offer Practical AI Course for Teaching Professionals
By TBT Online Desk
Spinoto Raises USD 149K in Pre-Seed Funding to Strengthen Technology and Scale Automobile Service Operations-TBT
Spinoto Raises USD 149K in Pre-Seed Funding to Strengthen Technology and Scale Automobile Service Operations
By TBT Online Desk

Read Next

AESL ₹4,700 crore Maharashtra transmission project, the blunt times
Business Vibes
AESL Wins Rs.4,700 Crore Maharashtra Power Project
August 26, 2026
2 Min Read
Vizhinjam International Seaport EXIM operations, the blunt times
Business Vibes
Vizhinjam Becomes New Gateway for India’s Global Trade
August 18, 2026
2 Min Read
JLite becomes Jainam App, the blunt times
Business Vibes
Jainam Rebrands JLite as Jainam App in Major Digital Identity Shift
June 15, 2026
2 Min Read
Mercury EV Tech NSE listing, the blunt times
Business Vibes
Gujarat : Mercury EV Tech makes strong NSE debut
June 2, 2026
2 Min Read
The Blunt Times

The Blunt Times is a 24-hour news portal from Surat and south Gujarat. It was launched by senior journalist Melvyn Thomas, who has over 21 years of experience working with the top news organizations such as The Indian Express, The Times of India, and The Economic Times.

Popular
Khavda Transmission Corridor. Powering India’s Green Transition
September 21, 2026
National Health Leaders Call for Coordinated Action to Accelerate Cervical Cancer Elimination in India
September 21, 2026
When Rabbits Stop Eating: Looking Beyond the Teeth – The Emerging Role of Cone Beam CT in Rabbit Dental Disease
September 21, 2026
Bench Mark Infotech Services Limited to Launch IPO on NSE Emerge; Offer Opens September 25, 2026
September 21, 2026
Categories
City Events
National
Business Vibes
Lifestyle
Business
Education
Entertainment
Spotlight
Regional
Health
Press Release
Sports

© 2026 All Rights Reserved, The Blunt Times

  • Terms of Service
  • Privacy Policy